Authors:
Nakamura, S
Hirano, T
Tsujimae, K
Aoyama, M
Kondo, K
Yamamura, Y
Mori, T
Tominaga, M
Citation: S. Nakamura et al., Antidiuretic effects of a nonpeptide vasopressin V-2-receptor agonist, OPC-51803, administered orally to rats, J PHARM EXP, 295(3), 2000, pp. 1005-1011
Authors:
Nakamura, S
Yamamura, Y
Itoh, S
Hirano, T
Tsujimae, K
Aoyama, M
Kondo, K
Ogawa, H
Shinohara, T
Kan, K
Tanada, Y
Teramoto, S
Sumida, T
Nakayama, S
Sekiguchi, K
Kambe, T
Tsujimoto, G
Mori, T
Tominaga, M
Citation: S. Nakamura et al., Characterization of a novel nonpeptide vasopressin V-2-agonist, OPC-51803,in cells transfected human vasopressin receptor subtypes, BR J PHARM, 129(8), 2000, pp. 1700-1706
Authors:
Yamamura, Y
Nakamura, S
Itoh, S
Hirano, T
Onogawa, T
Yamashita, T
Yamada, Y
Tsujimae, K
Aoyama, M
Kotosai, K
Ogawa, H
Yamashita, H
Kondo, K
Tominaga, M
Tsujimoto, G
Mori, T
Citation: Y. Yamamura et al., OPC-41061, a highly potent human vasopressin V-2-receptor antagonist: Pharmacological profile and aquaretic effect by single and multiple oral dosingin rats, J PHARM EXP, 287(3), 1998, pp. 860-867